These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 7525586

  • 1. Identification of a receptor candidate for the carboxyl-terminal cell binding domain of thrombospondins.
    Gao AG, Frazier WA.
    J Biol Chem; 1994 Nov 25; 269(47):29650-7. PubMed ID: 7525586
    [Abstract] [Full Text] [Related]

  • 2. Identification of a new cell adhesion motif in two homologous peptides from the COOH-terminal cell binding domain of human thrombospondin.
    Kosfeld MD, Frazier WA.
    J Biol Chem; 1993 Apr 25; 268(12):8808-14. PubMed ID: 8473325
    [Abstract] [Full Text] [Related]

  • 3. Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin.
    Gao AG, Lindberg FP, Finn MB, Blystone SD, Brown EJ, Frazier WA.
    J Biol Chem; 1996 Jan 05; 271(1):21-4. PubMed ID: 8550562
    [Abstract] [Full Text] [Related]

  • 4. Identification of active peptide sequences in the carboxyl-terminal cell binding domain of human thrombospondin-1.
    Kosfeld MD, Frazier WA.
    J Biol Chem; 1992 Aug 15; 267(23):16230-6. PubMed ID: 1644809
    [Abstract] [Full Text] [Related]

  • 5. Identification of SVTCG in thrombospondin as the conformation-dependent, high affinity binding site for its receptor, CD36.
    Li WX, Howard RJ, Leung LL.
    J Biol Chem; 1993 Aug 05; 268(22):16179-84. PubMed ID: 7688364
    [Abstract] [Full Text] [Related]

  • 6. Human platelet glycoprotein IIIb binds to thrombospondin fragments bearing the C-terminal region, and/or the type I repeats (CSVTCG motif), but not to the N-terminal heparin-binding region.
    Catimel B, Leung L, el Ghissasi H, Mercier N, McGregor J.
    Biochem J; 1992 May 15; 284 ( Pt 1)(Pt 1):231-6. PubMed ID: 1376110
    [Abstract] [Full Text] [Related]

  • 7. Cell-binding domain of endothelial cell thrombospondin: localization to the 70-kDa core fragment and determination of binding characteristics.
    Dardik R, Lahav J.
    Biochemistry; 1991 Sep 24; 30(38):9378-86. PubMed ID: 1716458
    [Abstract] [Full Text] [Related]

  • 8. Analysis of CD36 binding domains: ligand specificity controlled by dephosphorylation of an ectodomain.
    Asch AS, Liu I, Briccetti FM, Barnwell JW, Kwakye-Berko F, Dokun A, Goldberger J, Pernambuco M.
    Science; 1993 Nov 26; 262(5138):1436-40. PubMed ID: 7504322
    [Abstract] [Full Text] [Related]

  • 9. Activation of human neutrophils increases thrombospondin receptor expression.
    Suchard SJ, Boxer LA, Dixit VM.
    J Immunol; 1991 Jul 15; 147(2):651-9. PubMed ID: 1712815
    [Abstract] [Full Text] [Related]

  • 10. Stimulation of platelet activation and aggregation by a carboxyl-terminal peptide from thrombospondin binding to the integrin-associated protein receptor.
    Dorahy DJ, Thorne RF, Fecondo JV, Burns GF.
    J Biol Chem; 1997 Jan 10; 272(2):1323-30. PubMed ID: 8995439
    [Abstract] [Full Text] [Related]

  • 11. Thrombospondin mediates calcium mobilization in fibroblasts via its Arg-Gly-Asp and carboxyl-terminal domains.
    Tsao PW, Mousa SA.
    J Biol Chem; 1995 Oct 06; 270(40):23747-53. PubMed ID: 7559547
    [Abstract] [Full Text] [Related]

  • 12. Human microvascular endothelial cells adhere to thrombospondin-1 via an RGD/CSVTCG domain independent mechanism.
    Chen ZS, Pohl J, Lawley TJ, Swerlick RA.
    J Invest Dermatol; 1996 Feb 06; 106(2):215-20. PubMed ID: 8601718
    [Abstract] [Full Text] [Related]

  • 13. Thrombospondin modulates alpha v beta 3 function through integrin-associated protein.
    Gao AG, Lindberg FP, Dimitry JM, Brown EJ, Frazier WA.
    J Cell Biol; 1996 Oct 06; 135(2):533-44. PubMed ID: 8896608
    [Abstract] [Full Text] [Related]

  • 14. Sense and antisense cDNA transfection of CD36 (glycoprotein IV) in melanoma cells. Role of CD36 as a thrombospondin receptor.
    Silverstein RL, Baird M, Lo SK, Yesner LM.
    J Biol Chem; 1992 Aug 15; 267(23):16607-12. PubMed ID: 1379600
    [Abstract] [Full Text] [Related]

  • 15. A carboxyl terminal truncation mutant of CD36 is secreted and binds thrombospondin: evidence for a single transmembrane domain.
    Pearce SF, Wu J, Silverstein RL.
    Blood; 1994 Jul 15; 84(2):384-9. PubMed ID: 7517712
    [Abstract] [Full Text] [Related]

  • 16. CD36 peptides enhance or inhibit CD36-thrombospondin binding. A two-step process of ligand-receptor interaction.
    Leung LL, Li WX, McGregor JL, Albrecht G, Howard RJ.
    J Biol Chem; 1992 Sep 05; 267(25):18244-50. PubMed ID: 1381367
    [Abstract] [Full Text] [Related]

  • 17. Adhesion to thrombospondin by human embryonic fibroblasts is mediated by multiple receptors and includes a role for glycoprotein 88 (CD36).
    Stomski FC, Gani JS, Bates RC, Burns GF.
    Exp Cell Res; 1992 Jan 05; 198(1):85-92. PubMed ID: 1370062
    [Abstract] [Full Text] [Related]

  • 18. The properdin-like type I repeats of human thrombospondin contain a cell attachment site.
    Prater CA, Plotkin J, Jaye D, Frazier WA.
    J Cell Biol; 1991 Mar 05; 112(5):1031-40. PubMed ID: 1999454
    [Abstract] [Full Text] [Related]

  • 19. Thrombospondin as a mediator of cancer cell adhesion in metastasis.
    Walz DA.
    Cancer Metastasis Rev; 1992 Nov 05; 11(3-4):313-24. PubMed ID: 1384998
    [Abstract] [Full Text] [Related]

  • 20. Heparin-binding peptides from thrombospondins 1 and 2 contain focal adhesion-labilizing activity.
    Murphy-Ullrich JE, Gurusiddappa S, Frazier WA, Höök M.
    J Biol Chem; 1993 Dec 15; 268(35):26784-9. PubMed ID: 8253815
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.